LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Sun Pharma advances on inking strategic distribution pact with Mitsubishi Tanabe Pharma

Sun Pharma advances on inking strategic distribution pact with Mitsubishi Tanabe Pharma (06-Sep-2016)

Sun Pharmaceutical Industries is currently trading at Rs. 783.95, up by 1.85 points or 0.24% from its previous closing of Rs. 782.10 on the BSE.

The scrip opened at Rs. 785.00 and has touched a high and low of Rs. 789.40 and Rs. 782.00 respectively. So far 46618 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 933.70 on 08-Oct-2015 and a 52 week low of Rs. 706.40 on 24-Nov-2015.

Last one week high and low of the scrip stood at Rs. 789.40 and Rs. 747.00 respectively. The current market cap of the company is Rs. 188689.51 crore.

The promoters holding in the company stood at 54.97%, while institutions and non-institutions held 34.96% and 10.07% respectively.

Sun Pharmaceutical Industries has signed a strategic distribution alliance with Mitsubishi Tanabe Pharma Corporation for these 14 prescription brands. Under this alliance, following the transfer of manufacturing & marketing rights to Sun Pharma's subsidiary in Japan, Mitsubishi Tanabe Pharma Corporation will market and distribute all the 14 brands as well as provide information on their proper use to healthcare professionals.

The pharma major initiated a phased transfer of manufacturing & marketing rights in Japan for the 14 long-listed/established prescription brands acquired from Novartis. These 14 prescription brands acquired by the company earlier this year will be transferred from Novartis Pharma K.K. to Sun Pharma's subsidiary in Japan beginning October 2016.


Top News Today
Wintac gets nod for slump sale of pharmaceutical business undertaking
(27-Apr-2018)

Wintac gets nod for slump sale of pharmaceutical business undertakingWintac's board has approved the proposal to effect slump sale of the Pharmaceutical Business Undertaking of the company to Par Formulations. The board of directors of the company at their meeting held......click on news to read complete article.

Reliance Capital reports marginal rise in Q4 consolidated net profit
(27-Apr-2018)

Reliance Capital reports marginal rise in Q4 consolidated net profitReliance Capital has reported results for the fourth quarter and year ended March 31, 2018.The company has reported a rise of 36.77% in its net profit at Rs 212 crore for the quarter ended March 31, 2018......click on news to read complete article.

Capital India Finance planning to raise funds
(27-Apr-2018)

Capital India Finance planning to raise fundsCapital India Finance is planning to borrow/ raise funds in Indian/foreign currency by issue of debt securities, including but not limited to non-convertible debentures, bonds, MTN. The meeting of the......click on news to read complete article.

International Stock News
Asian markets trade mostly higher on Friday
(27-Apr-2018)

Asian markets trade mostly higher on FridayAll the Asian markets barring Shanghai Composite are trading in green terrain on Friday as investors' concerns over geopolitical risks eased on looming trade talks between the U.S. and China and the leaders......click on news to read complete article.

US markets closed higher; Dow logs best one-day gain in two weeks
(27-Apr-2018)

US markets closed higher; Dow logs best one-day gain in two weeksThe US markets closed higher on Thursday, with the Dow Jones Industrial Average booked its best one-day gain in about two weeks and the broader market all saw gains of at least 1% on the back of better-than-expected......click on news to read complete article.

Asian markets trade mostly lower in early deals on Thursday
(26-Apr-2018)

Asian markets trade mostly lower in early deals on ThursdayMost of the Asian equity benchmarks are trading lower in the early deals on Thursday, following the lackluster cues overnight from Wall Street. Though, Japan's Nikkei share average rose, buoyed by gains......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.